Publications by authors named "B Nawrocki-Raby"

Claim this Profile
A
AXL expression to predict resistance to immunotherapy in metastatic non-small cell lung cancer.
Julien Ancel, Maxime Dewolf, Béatrice Nawrocki-Raby, Anne Durlach, Véronique Dalstein

Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing neutrophil-to-lymphocyte ratio (NLR), absolute neutrophil count (ANC) and derived NLR as predictive biomarkers in first-line immunotherapy for non-small cell lung cancer: a retrospective study.
Elise Longueville, Maxime Dewolf, Véronique Dalstein, Anne Durlach, Alexandre Vivien, Béatrice Nawrocki-Raby

Transl Lung Cancer Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LRP1 involvement in FHIT-regulated HER2 signaling in non-small cell lung cancer.
Théophile Ponchel, Emma Loeffler, Julien Ancel, Audrey Brisebarre, Nathalie Lalun, Béatrice Nawrocki-Raby

Eur J Cell Biol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies.
Emma Loeffler, Julien Ancel, Véronique Dalstein, Gaëtan Deslée, Myriam Polette, Béatrice Nawrocki-Raby

Life (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic FHIT/pHER2 signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer.
Audrey Brisebarre, Julien Ancel, Théophile Ponchel, Emma Loeffler, Adeline Germain, Béatrice Nawrocki-Raby

Front Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis